The global collagen supplements market is projected to grow from USD 6.0 billion in 2025 to USD 16.8 billion by 2033, while Europe's collagen supplements market is forecast to reach USD 1.41 billion by 2031. Ready-to-drink collagen drinks and shots are emerging as a particularly dynamic format in Europe, with a projected 9.93% CAGR through 2031.
Sequoya Biotechnologies introduces a new white label collagen range comprising 25 ml collagen shots and liquid collagen concentrates, designed for supplement, beauty-from-within and wellness brands. The article examines collagen market trends, scientific research on collagen peptides, liquid supplement opportunities and the growing demand for private label collagen manufacturing in Europe.
